Spiriva Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Podcasts
• Alerts
• Clinical Trials
• Forums

Effectiveness of Tiotropium + Olodaterol Versus Inhaled Corticosteroids (ICS) + Long-acting β2-agonists (LABA) Among COPD Patients in Taiwan
Condition:   Pulmonary Disease, Chronic Obstructive Interventions:   Drug: Tiotropium (Tio);   Drug: Inhaled corticosteroids (ICS);   Drug: Olodaterol (Olo);   Drug: Long-acting β2-agonists (LABA);   Device: Combined Inhaler Sponsor:   Boehringer Ingelheim Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 2, 2022 Category: Research Source Type: clinical trials

Safety of Tiotropium + Olodaterol in Chronic Obstructive Pulmonary Disease (COPD) Patients in Taiwan: a Non-interventional Study Based on the Taiwan National Health Insurance (NHI) Data
Condition:   Pulmonary Disease, Chronic Obstructive Interventions:   Drug: Tiotropium+Olodaterol;   Device: Spiolto Respimat;   Drug: Long-acting muscarinic antagonists (LAMAs);   Drug: Long-acting β2-agonists (LABAs) Sponsor:   Boehringer Ingelheim Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 26, 2022 Category: Research Source Type: clinical trials